SANJIVANI PARANTERAL LTD. (SANJIVIN) fair value: what the stock is really worth
As of Nov 19, 2026: fair value (intrinsic value) of SANJIVANI PARANTERAL LTD. stock ₹115, price ₹173, that is 33.4% below the price, quality 32 out of 100. Rating: overvalued. Calculated from audited financials with 16 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
SANJIVANI PARANTERAL LTD.
SANJIVIN · BSEExpensive (fair value 33% below the price), weak company and falling price: meets none of the 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 17, 2026.
How to read this chart
60‑month range ₹11.18 – ₹387.64 · fair‑value band ₹83.50 – ₹146.68 · the ₹173.05 price screens above the ₹115.22 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 17, 2026.
Every Wednesday you see whether SANJIVANI PARANTERAL is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Sanjivani Paranteral Limited operates as a pharmaceutical company in India.
Show moreShow less
It manufactures pharmaceutical products in a form of oral solids, small volume parenteral, and sterile powder formulations for various therapeutic areas comprising central nervous system, cardiovascular system, antibiotics, gastroenterological, anti-diabetics, and anti-allergic.
It also offers soft gels, topicals, nasal sprays, liquid injection, capsules, tablets, dry syrups, and ear/eye drops. The company also exports its products. Sanjivani Paranteral Limited was incorporated in 1994 and is headquartered in Mumbai, India.
Stock analysis
SANJIVANI PARANTERAL LTD. (SANJIVIN) currently trades at ₹173.05, while our model-based Fair Value estimate is ₹115.22, 33% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ₹119.28 per share, and 1 of the 16 models we run sit above the ₹173.05 price.
Bear case: the Asset-Based group reads lowest at ₹25.46, and 15 of the 16 models stay below the price. Data coverage for this calculation is medium.
Scenario range: ₹83.50 (bear) to ₹146.68 (bull), the price of ₹173.05 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 32/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
SANJIVANI PARANTERAL LTD. reported revenue of ₹687M in FY2026 versus ₹304M in FY2022, a compound +22.6%/yr. Reported net income was ₹66.9M in FY2026, compounding +8.4%/yr from FY2022.
Key figures
Market cap ₹2.1B (≈ $22.7M) Micro · P/E ratio 28.6 · P/S ratio 2.85 · EPS (TTM) ₹6.06 · Net margin 10.1% · Return on equity 14.8% · Return on assets (EBIT) 17.0% (5-year average) · Operating margin 14.8%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 48 out of 100 (low confidence).
What moves the price
The share trades about 28% below its 52-week high and 34% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −27% fair-value upside, at −33%, SANJIVIN screens richer than that median.
Fair Value models
All 16 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
SANJIVIN screens overvalued: fair value 33% below the price. Compare with Merck KGaA →
Compare SANJIVANI PARANTERAL LTD. with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 608 stocks
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Quality Score by industry
- Return on equity by industry
- Piotroski F-Score screener with fair value
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Zoetis Inc ZTS | $85.57 | $113.53 | +33% | vs SANJIVIN |
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥46.88 | ¥52.43 | +12% | vs SANJIVIN |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,900 | ₹1,983 | +4% | vs SANJIVIN |
| Haleon plc HLN | $9.08 | $8.47 | −7% | vs SANJIVIN |
| Merck KGaA MRK | €148.40 | €108.83 | −27% | vs SANJIVIN |
| Galderma Group GALD | CHF 184.70 | CHF 112.46 | −39% | vs SANJIVIN |
| Takeda Pharmaceutical Company TAK | $21.27 | $11.23 | −47% | vs SANJIVIN |
| Sandoz Group SDZ | CHF 81.24 | CHF 41.06 | −49% | vs SANJIVIN |
| Teva Pharmaceutical Industries Limited TEVA | $42.23 | $20.74 | −51% | vs SANJIVIN |
| Divi's Laboratories Limited DIVISLAB | ₹11,178 | ₹1,567 | −86% | vs SANJIVIN |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is SANJIVANI PARANTERAL LTD. (SANJIVIN) overvalued or undervalued?
What is the fair value of SANJIVIN?
What is the quality score of SANJIVIN?
What is the price target for SANJIVANI PARANTERAL LTD. (SANJIVIN)?
What is the SANJIVANI PARANTERAL LTD. stock forecast for 2026?
What is the revenue of SANJIVANI PARANTERAL LTD. (SANJIVIN)?
What is the intrinsic value of SANJIVANI PARANTERAL LTD. (SANJIVIN)?
Is SANJIVANI PARANTERAL LTD. stock overvalued or undervalued in 2026?
Is fair value the same as the market price of SANJIVIN?
How much is SANJIVANI PARANTERAL LTD. worth?
What do the bullish and bearish scenarios say about SANJIVIN?
What is the P/E ratio of SANJIVIN?
How solid is the balance sheet of SANJIVANI PARANTERAL LTD. (SANJIVIN)?
How far is SANJIVIN from its 52-week high?
Which stocks are comparable to SANJIVANI PARANTERAL LTD.?
Is SANJIVANI PARANTERAL LTD. stock attractive at the current price?
How is the fair value of SANJIVIN calculated?
Is it still worth investing in stocks now?
What is the share price of SANJIVANI PARANTERAL LTD. (SANJIVIN)?
What should I pay attention to with SANJIVANI PARANTERAL LTD. right now?
Key figures of SANJIVANI PARANTERAL LTD.
How large is the market capitalisation of SANJIVANI PARANTERAL LTD. (SANJIVIN)?
What is the P/S ratio of SANJIVANI PARANTERAL LTD. (SANJIVIN)?
What are the earnings per share of SANJIVANI PARANTERAL LTD. (SANJIVIN)?
What is the net margin of SANJIVANI PARANTERAL LTD. (SANJIVIN)?
What is the return on equity of SANJIVANI PARANTERAL LTD. (SANJIVIN)?
What is the EBIT return on assets of SANJIVANI PARANTERAL LTD. (SANJIVIN)?
What is the operating margin of SANJIVANI PARANTERAL LTD. (SANJIVIN)?
How fast is revenue growing at SANJIVANI PARANTERAL LTD. (SANJIVIN)?
How fast are earnings growing at SANJIVANI PARANTERAL LTD. (SANJIVIN)?
How much free cash flow does SANJIVANI PARANTERAL LTD. (SANJIVIN) generate?
How much net debt does SANJIVANI PARANTERAL LTD. (SANJIVIN) carry?
Watch SANJIVANI PARANTERAL LTD. in the live analysis
One click puts SANJIVANI PARANTERAL LTD. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.